USA-104 — Portland, Oregon

USA-104 is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

USA-104 has participated in 2 clinical trials.

Therapeutic areas: Atopic Dermatitis.

Sponsors: Evelo Biosciences, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

• Oregon Health and Science University, CHH1
• Oregon Health & Science University (OHSU), Site 048
• Oregon Health & Science University OHS University
• Oregon Health and Science University, Doernbecher Children's Hospital
• Oregon Health Sciences University Hospital
• Oregon Health & Science University OHSU Knight Cancer Institute
• Oregon Health and Science University /ID# 149774
• Legacy Emanuel Research Hospital Portland
• Oregon Health and Science University /ID# 221801
• Oregon Health Sciences University SC-6
• Oregon Health and Science University Dept. Hematologic Malignancies
• VA Portland Health Care Services

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USA-104?

USA-104 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USA-104 conducted?

USA-104 has 2 clinical trials on record. Their work covers Atopic Dermatitis.

Is USA-104 accredited by Crixeo Clinical Trials?

USA-104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USA-104?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.